Our previous studies demonstrated that IL-12/ms treatment during gonococcal infection induced the production of vaginal and serum IgG antibodies, as well as vaginal IgA antibodies against the homologous infecting strain of N. gonorrhoeae (8). The gene discussed is CD79A; the disease is bacterial sexually transmitted disease.